INOVIO PHARMACEUTICALS, INC. Quarterly Depreciation in USD from Q1 2011 to Q1 2024

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: Inovio Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2011 to Q1 2024.
Inovio Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $424K, a 40% decline year-over-year.
Inovio Pharmaceuticals, Inc. annual Depreciation for 2023 was $2.62M, a 28.3% decline from 2022.
Inovio Pharmaceuticals, Inc. annual Depreciation for 2022 was $3.66M, a 20.3% increase from 2021.
Inovio Pharmaceuticals, Inc. annual Depreciation for 2021 was $3.04M, a 0.04% increase from 2020.

Depreciation, Quarterly (USD)

Depreciation, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	$424K	-$283K	-40%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-13
Q1 2023	$707K	-$222K	-23.9%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-13
Q1 2022	$929K	+$269K	+40.7%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-10
Q1 2021	$661K	-$149K	-18.4%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-10
Q1 2020	$810K	-$121K	-13%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-10
Q1 2019	$931K	+$33.2K	+3.7%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-11
Q1 2018	$898K	+$375K	+71.9%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-09
Q1 2017	$522K	+$134K	+34.7%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-09
Q1 2016	$388K	+$174K	+81.3%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-10
Q1 2015	$214K	+$98.5K	+85.2%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-09
Q1 2014	$116K	+$75.7K	+190%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-11
Q1 2013	$39.8K	+$3.03K	+8.22%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-12
Q1 2012	$36.8K	+$4.48K	+13.9%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-10
Q1 2011	$32.3K			Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-09

* An asterisk sign (*) next to the value indicates that the value is likely invalid.